Stay updated on Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows recruitment is closed and adds new navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment label formatting and marks the page revision as v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T08:30:39.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page’s revision indicator updated from v3.5.4 to v3.5.5, indicating a newer page release. No substantive study details were altered.
    Difference
    0.1%
    Check dated 2026-06-08T04:41:55.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.4, indicating a new version of the study record is live; this change affects only metadata rather than the substantive study information.
    Difference
    0.1%
    Check dated 2026-05-18T03:48:50.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from **v3.5.0** to **v3.5.3**, reflecting a change in the ClinicalTrials.gov front-end release without altering the displayed study information.
    Difference
    0.1%
    Check dated 2026-04-26T15:26:39.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now shown, replacing Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T19:02:32.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T07:45:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.